Reprogramming to resist

Science. 2017 Jan 6;355(6320):29-30. doi: 10.1126/science.aam5355.

Authors

Kathleen Kelly¹, Steven P Balk²

Affiliations

¹ Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. [email protected].
² Hematology-Oncology Division and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

PMID: 28059730
DOI: 10.1126/science.aam5355

No abstract available

Publication types

Comment

MeSH terms

Cellular Reprogramming*
Humans
Induced Pluripotent Stem Cells*